Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Advertisement

Enliven Therapeutics (ELVN) Similar Stocks

Compare
305 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Enliven Therapeutics
$19.64
$1.13B
-9.50
-9.59%
8 Buy
0 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.81
$1.89B
-82.01%
4 Buy
12 Hold
5 Sell
Hold
Viridian Therapeutics
$28.77
$2.10B
-5.29
42.85%
13 Buy
0 Hold
0 Sell
Strong Buy
Cidara Therapeutics
$217.71
$6.84B
1415.03%
4 Buy
4 Hold
0 Sell
Moderate Buy
Intellia Therapeutics
$8.70
$1.01B
-37.72%
9 Buy
12 Hold
1 Sell
Moderate Buy
AbCellera Biologics
$3.69
$1.10B
39.25%
3 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ELVN
Enliven Therapeutics
22.07
-2.83
-11.37%
SRPT
Sarepta Therapeutics
18.81
-85.86
-82.03%
VRDN
Viridian Therapeutics
28.77
8.43
41.45%
CDTX
Cidara Therapeutics
217.71
202.75
1355.28%
NTLA
Intellia Therapeutics
8.70
-5.47
-38.60%
ABCL
AbCellera Biologics
3.69
1.04
39.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis